Boenning & Scattergood’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Boenning & Scattergood’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,270	Closed	-$219K	–	286
2019 Q2	$219K	Buy	1,270 +20	+2%	+$3.46K	0.06%	256
2019 Q1	$211K	Buy	+1,250	New	+$186K	0.06%	266
2018 Q4	–	Sell	-1,400	Closed	-$242K	–	289
2018 Q3	$242K	Sell	1,400 -350	-20%	-$50.5K	0.08%	240
2018 Q2	$244K	Buy	+1,750	New	+$249K	0.08%	244

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boenning & Scattergood's GWPH Position: Q3 2019 in Review

Boenning & Scattergood sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 1,270 shares — an estimated $219K sold.

Boenning & Scattergood first reported a position in GWPH in Q2 2018 and held it in 4 quarters. The position peaked at $244K in Q2 2018. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Boenning & Scattergood reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Boenning & Scattergood sold 1,270 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $219K.
Boenning & Scattergood first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 4 quarters.
Boenning & Scattergood's GW Pharmaceuticals Plc American Depositary Shares position peaked at $244K in Q2 2018.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Boenning & Scattergood's 13F filing for Q3 2019, filed 15 Oct 2019.